Korro Bio (KRRO) Other financing activities (2018 - 2026)

Korro Bio (KRRO) has reported Other financing activities for 8 consecutive years, with -$21000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other financing activities fell 520.0% year-over-year to -$21000.0; the trailing twelve-month figure through Jun 2026 stood at $5.5 million (down 94.48% YoY), and the FY2025 full-year result was $685000.0, down 98.98% from the prior year.
• Other financing activities eased to -$21000.0 in Q2 2026 per KRRO's latest filing, from $5.0 million in the prior quarter.
• Across five years, Other financing activities topped out at $100.0 million in Q4 2024 and bottomed at -$2.4 million in Q3 2023.
• Historically, Other financing activities has averaged $10.9 million across 5 years, with a median of $133500.0 in 2022.
• The sharpest annual moves came in 2022 and 2024: Other financing activities plunged 13300.0% in 2022, then soared 88580.26% in 2024.
• Over 5 years, Other financing activities stood at -$134000.0 in 2022, then surged by 2589.55% to $3.3 million in 2023, then surged by 2897.6% to $100.0 million in 2024, then sank by 99.62% to $380000.0 in 2025, then plunged by 105.53% to -$21000.0 in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered -$21000.0, $5.0 million, and $380000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.